Shanghai Pulmonary Hospital, Shanghai, China
Clinical trials sponsored by Shanghai Pulmonary Hospital, Shanghai, China, explained in plain language.
-
New pill before surgery shows promise for hard-to-treat lung cancer
Disease control OngoingThis study tests a drug called sunvozertinib given before surgery for people with stage II to IIIB non-small cell lung cancer that has a specific genetic change (EGFR exon 20 insertion). The goal is to see if the drug can shrink tumors and improve outcomes. About 24 participants …
Phase: PHASE2 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Disease control
Last updated May 26, 2026 10:03 UTC
-
New combo therapy shows promise for shrinking lung tumors before surgery
Disease control OngoingThis study tests whether combining the immunotherapy drug toripalimab with targeted radiation (SBRT) before surgery can shrink tumors in people with stage IIA to IIIB non-small cell lung cancer. About 40 adults aged 18-75 who are eligible for surgery will receive the treatment. T…
Phase: PHASE2 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Disease control
Last updated May 22, 2026 13:50 UTC